What is Surgical Direct?
Headquartered in Deland, Florida, Surgical Direct operates as a specialized provider of medical, scientific, and veterinary products. The company distinguishes itself through a comprehensive portfolio that spans laparoscopy, arthroscopy, and surgical instrumentation, supported by an inventory of over 17,000 distinct products. By prioritizing efficient manufacturing and maintaining deep-rooted relationships with healthcare professionals, the firm ensures that clinical environments have immediate access to essential equipment. Their business model is centered on enhancing patient outcomes through cost-effective, high-quality medical solutions, effectively bridging the gap between complex surgical requirements and streamlined procurement processes.
How much funding has Surgical Direct raised?
Surgical Direct has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Surgical Direct
PPP
Public-Private Partnership
What's next for Surgical Direct?
With the recent capital deployment, Surgical Direct is poised to accelerate its strategic initiatives, focusing on the expansion of its service and repair divisions while optimizing its North American distribution network. The company's roadmap emphasizes the integration of advanced research and development to stay ahead of market trends in surgical technology. By further investing in its collaborative corporate environment and customer-centric service model, Surgical Direct aims to solidify its market share in the diagnostic and surgical instrumentation sectors. Future growth will likely be driven by the scaling of its disposable product lines and the enhancement of its digital procurement platforms, ensuring that the company remains a preferred partner for medical facilities seeking reliability and clinical excellence.
See full Surgical Direct company page
